EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 94 filers reported holding EPIZYME INC in Q4 2016. The put-call ratio across all filers is 3.03 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $578,000 | -25.2% | 393,000 | -41.5% | 0.00% | 0.0% |
| Q1 2022 | $773,000 | -39.3% | 671,788 | +31.9% | 0.00% | -50.0% |
| Q4 2021 | $1,273,000 | +164.1% | 509,188 | +777.7% | 0.00% | +100.0% |
| Q2 2021 | $482,000 | -82.0% | 58,011 | -77.7% | 0.00% | -50.0% |
| Q3 2019 | $2,683,000 | -50.5% | 260,088 | -39.8% | 0.00% | -60.0% |
| Q2 2019 | $5,419,000 | +416.1% | 431,788 | +153.4% | 0.01% | +400.0% |
| Q4 2018 | $1,050,000 | -46.1% | 170,388 | +9.7% | 0.00% | -50.0% |
| Q4 2017 | $1,949,000 | -55.6% | 155,276 | -32.6% | 0.00% | -60.0% |
| Q3 2017 | $4,389,000 | +44.8% | 230,388 | +14.7% | 0.01% | +25.0% |
| Q2 2017 | $3,032,000 | +53.5% | 200,788 | +74.3% | 0.00% | +33.3% |
| Q1 2017 | $1,975,000 | +11.3% | 115,188 | -36.1% | 0.00% | 0.0% |
| Q3 2016 | $1,774,000 | +1044.5% | 180,288 | +1094.9% | 0.00% | – |
| Q2 2016 | $155,000 | -56.5% | 15,088 | -48.7% | 0.00% | -100.0% |
| Q1 2016 | $356,000 | – | 29,388 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |